checkAd
    Startseite > Aktien > Inozyme Pharma > Nachrichten
    Inozyme Pharma Aktie
    4,5100
     
    USD
    -1,53 %
    -0,0700 USD
    Letzter Kurs 02:00:00 Nasdaq
    4,5000
     
    USD
    5.100 STK
    Geldkurs 19.04.24
    4,5100
     
    USD
    3.000 STK
    Briefkurs 19.04.24
    ISIN: US45790W1080 · WKN: A2P86D · SYM: INZY · USA

    Neueste Nachrichten

    Inozyme Pharma Announces Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency (PXE) and ENPP1 Deficiency
    08.04.24 · globenewswire · Inozyme Pharma
    Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    06.04.24 · globenewswire · Inozyme Pharma
    Inozyme Pharma to Participate at the 23rd Annual Needham Virtual Healthcare Conference
    02.04.24 · globenewswire · Inozyme Pharma
    Inozyme Pharma to Report Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency and ENPP1 Deficiency on April 8, 2024
    26.03.24 · globenewswire · Inozyme Pharma
    Inozyme Pharma Reports Full Year 2023 Financial Results and Provides Business Highlights
    12.03.24 · globenewswire · Inozyme Pharma
    Inozyme Pharma to Participate in the TD Cowen 44th Annual Health Care Conference
    26.02.24 · globenewswire · Inozyme Pharma
    Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    06.02.24 · globenewswire · Inozyme Pharma
    Inozyme Pharma to Participate in Upcoming Investor Conferences
    09.11.23 · globenewswire · Inozyme Pharma
    Inozyme Pharma Reports Third Quarter 2023 Financial Results and Provides Business Highlights
    07.11.23 · globenewswire · Inozyme Pharma
    Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    03.11.23 · globenewswire · Inozyme Pharma
    Inozyme Pharma Announces Presentation at the American Society of Nephrology (ASN) Kidney Week 2023
    26.10.23 · globenewswire · Inozyme Pharma
    Inozyme Pharma Highlights Inclusion of Generalized Arterial Calcification of Infancy (GACI) in Genomics England’s Generation Study of Rare Conditions
    10.10.23 · globenewswire · Inozyme Pharma